C. R. Bard was founded in 1907 by Charles R. Bard as an importer of Gomenol, a medication used to treat urinary discomfort.
In 1928 Bard sold the company to John F. Willits and Edson L. Outwin, who expanded the business by selling the Foley catheter in 1934 and the American Woven Catheter in 1940.
In 1948 C. R. Bard’s sales reached $1 million for the first time. At the same time the company continued to innovate in with new and better types of catheters.
Today the company’s Foley urological catheter is still a best seller. C. R. Bard operates through four divisions: Vascular, Oncology, Urology, and Surgical Specialties. Products include stents, catheters for delivering chemotherapy treatments, urology catheters, specialty surgical tools, and guidewires used in angioplasties and other vascular procedures.
C. R. Bard trades publicly on the New York Stock Exchange under the ticker symbol BCR, is a member of the S&P 500, is #720 in the Fortune 1000, and had $3.32 billion in revenue in 2014.
C. R. BardC. R. Bard was founded in 1907 by Charles R. Bard as an importer of Gomenol, a medication used to treat urinary discomfort.
In 1928 Bard sold the company to John F. Willits and Edson L. Outwin, who expanded the business by selling the Foley catheter in 1934 and the American Woven Catheter in 1940.
In 1948 C. R. Bard’s sales reached $1 million for the first time. At the same time the company continued to innovate in with new and better types of catheters.
History
Today the company’s Foley urological catheter is still a best seller. C. R. Bard operates through four divisions: Vascular, Oncology, Urology, and Surgical Specialties. Products include stents, catheters for delivering chemotherapy treatments, urology catheters, specialty surgical tools, and guidewires used in angioplasties and other vascular procedures.
C. R. Bard trades publicly on the New York Stock Exchange under the ticker symbol BCR, is a member of the S&P 500, is #720 in the Fortune 1000, and had $3.32 billion in revenue in 2014.